Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Human leptospirosis in The Federated States of Micronesia: a hospital-based febrile illness survey

Authors: Susannah Colt, Boris I Pavlin, Jacob L Kool, Eliaser Johnson, Judith P McCool, Alistair J Woodward

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Human leptospirosis is an emerging infectious disease of global significance, and is endemic to several countries in the Pacific. Zoonotic transmission dynamics combined with diagnostic challenges lead to difficulties in prevention and identification of cases. The Federated States of Micronesia (FSM) lacks surveillance data for human leptospirosis. This hospital-based serologic survey sought to estimate the burden of leptospirosis, collect information relating to associated factors, and assess the leptospirosis point-of-care rapid diagnostic test (RDT) commonly used in FSM.

Methods

A four-month hospital-based survey was conducted in Pohnpei State, FSM in 2011. Patients with undifferentiated fevers presenting to hospital were referred for enrolment by physicians. Consenting participants provided paired blood specimens 10–30 days apart, and responded to interview questions regarding demographics, clinical symptoms, exposure to animals, and environmental exposure. Blood samples were subjected to immunochromatographic RDT and confirmed by microscopic agglutination test (MAT).

Results

Of 54 participants tested by MAT, 20.4% (95% confidence interval [CI] 10.1–30.6%) showed serologic evidence of acute infection. Occupation student (odds ratio [OR], 17.5; 95% CI: 1.9–161.1) and recreational gardening (OR, 8.6; 95% CI: 1.0-73.8), identified by univariate logistic regression, were associated with infection. The local rapid diagnostic test (RDT) performed with a sensitivity of 69.2 (42.3-89.3 CI) and specificity of 90.0 (81.6-95.6 CI) compared to MAT.

Conclusions

This study demonstrated a high burden of leptospirosis in Pohnpei. Further work is warranted to identify additional risk factors and opportunities to control leptospirosis in Pohnpei and other Pacific settings.
Literature
1.
go back to reference Adler B, de la Peña Moctezuma A: Leptospira and leptospirosis. Vet Microbiol. 2010, 140 (3–4): 287-296.CrossRefPubMed Adler B, de la Peña Moctezuma A: Leptospira and leptospirosis. Vet Microbiol. 2010, 140 (3–4): 287-296.CrossRefPubMed
2.
go back to reference World Health Organization: Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. 2003 World Health Organization: Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. 2003
3.
go back to reference Abela-Ridder B, Sikkema R, Hartskeerl RA: Estimating the burden of human leptospirosis. Int J Antimicrob Agents. 2010, 36: S5-S7.CrossRefPubMed Abela-Ridder B, Sikkema R, Hartskeerl RA: Estimating the burden of human leptospirosis. Int J Antimicrob Agents. 2010, 36: S5-S7.CrossRefPubMed
4.
go back to reference Control of Communicable Diseases Manual. Edited by: Heymann DL. 2008, Washington, DC: American Public Health Association, 19 Control of Communicable Diseases Manual. Edited by: Heymann DL. 2008, Washington, DC: American Public Health Association, 19
5.
go back to reference Vijayachari P, Sugunan AP, Shriram AN: Leptospirosis: an emerging global public health problem. J Biosci. 2008, 33 (4): 557-569. 10.1007/s12038-008-0074-z.CrossRefPubMed Vijayachari P, Sugunan AP, Shriram AN: Leptospirosis: an emerging global public health problem. J Biosci. 2008, 33 (4): 557-569. 10.1007/s12038-008-0074-z.CrossRefPubMed
7.
go back to reference Zavitsanou A, Babatsikou F: Leptospirosis: epidemiology and preventive measures. Health Sci J. 2008, 2 (2): 75-82. Zavitsanou A, Babatsikou F: Leptospirosis: epidemiology and preventive measures. Health Sci J. 2008, 2 (2): 75-82.
8.
go back to reference World Health Organization: Report of the First Meeting of the Leptospirosis Burden Epidemiology Reference Group. 2009, Geneva, Switzerland: World Health Organization World Health Organization: Report of the First Meeting of the Leptospirosis Burden Epidemiology Reference Group. 2009, Geneva, Switzerland: World Health Organization
9.
go back to reference Victoriano A, Smythe L, Gloriani-Barzaga N, Cavinta L, Kasai T, Limpakarnjanarat K, Ong B, Gongal G, Hall J, Coulombe C, Yanagihara Y, Yoshida S, Adler B: Leptospirosis in the Asia Pacific region. BMC Infect Dis. 2009, 9 (1): 147-10.1186/1471-2334-9-147.CrossRefPubMedPubMedCentral Victoriano A, Smythe L, Gloriani-Barzaga N, Cavinta L, Kasai T, Limpakarnjanarat K, Ong B, Gongal G, Hall J, Coulombe C, Yanagihara Y, Yoshida S, Adler B: Leptospirosis in the Asia Pacific region. BMC Infect Dis. 2009, 9 (1): 147-10.1186/1471-2334-9-147.CrossRefPubMedPubMedCentral
10.
go back to reference Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N: The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis. 2008, 12 (4): 351-357. 10.1016/j.ijid.2007.09.011.CrossRefPubMed Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N: The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis. 2008, 12 (4): 351-357. 10.1016/j.ijid.2007.09.011.CrossRefPubMed
11.
go back to reference Berlioz-Arthaud A, Kiedrzynski T, Singh N, Yvon J-F, Roualen G, Coudert C, Uluiviti V: Multicentre survey of incidence and public health impact of leptospirosis in the Western Pacific. Trans R Soc Trop Med Hyg. 2007, 101 (7): 714-721. 10.1016/j.trstmh.2007.02.022.CrossRefPubMed Berlioz-Arthaud A, Kiedrzynski T, Singh N, Yvon J-F, Roualen G, Coudert C, Uluiviti V: Multicentre survey of incidence and public health impact of leptospirosis in the Western Pacific. Trans R Soc Trop Med Hyg. 2007, 101 (7): 714-721. 10.1016/j.trstmh.2007.02.022.CrossRefPubMed
12.
go back to reference Kato Y, Gibo Y, Mori M, Ishibashi M, Kaneuchi C: Survey of antibodies to Leptospira in humans and wild rats in Pohnpei, Federated States of Micronesia. J Jpn Vet Med Assoc. 1992, 45 (7): 503-506.CrossRef Kato Y, Gibo Y, Mori M, Ishibashi M, Kaneuchi C: Survey of antibodies to Leptospira in humans and wild rats in Pohnpei, Federated States of Micronesia. J Jpn Vet Med Assoc. 1992, 45 (7): 503-506.CrossRef
13.
go back to reference Robertson AS, Upson D, Dever G, Tipene-Leach D: Community-based research and medical education: the PBMOTB experience with dengue, leptospirosis, TB and intestinal parasites. Pac Health Dialog. 1996, 3 (2): 178-186. Robertson AS, Upson D, Dever G, Tipene-Leach D: Community-based research and medical education: the PBMOTB experience with dengue, leptospirosis, TB and intestinal parasites. Pac Health Dialog. 1996, 3 (2): 178-186.
14.
go back to reference Simms JR: Animal leptospirosis in the Federated States of Micronesia. Pac Health Dialog. 1998, 5 (1): 30-37. Simms JR: Animal leptospirosis in the Federated States of Micronesia. Pac Health Dialog. 1998, 5 (1): 30-37.
15.
go back to reference Pavlin B: Draft Mission Report: Suspected Systemic Febrile Illness Outbreak. 2010, Chuuk State, Federated States of Micronesia: World Health Organization, Office of the South Pacific Pavlin B: Draft Mission Report: Suspected Systemic Febrile Illness Outbreak. 2010, Chuuk State, Federated States of Micronesia: World Health Organization, Office of the South Pacific
16.
go back to reference Epstein PR: Climate change and human health. N Engl J Med. 2005, 353 (14): 1433-1436. 10.1056/NEJMp058079.CrossRefPubMed Epstein PR: Climate change and human health. N Engl J Med. 2005, 353 (14): 1433-1436. 10.1056/NEJMp058079.CrossRefPubMed
17.
go back to reference World Organization for Animal Health: Leptospirosis. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 2012, 7 World Organization for Animal Health: Leptospirosis. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 2012, 7
18.
go back to reference Lau CL, Skelly C, Smythe LD, Craig SB, Weinstein P: Emergence of new leptospiral serovars in American Samoa-ascertainment or ecological change?. BMC Infect Dis. 2012, 12 (1): 19-10.1186/1471-2334-12-19.CrossRefPubMedPubMedCentral Lau CL, Skelly C, Smythe LD, Craig SB, Weinstein P: Emergence of new leptospiral serovars in American Samoa-ascertainment or ecological change?. BMC Infect Dis. 2012, 12 (1): 19-10.1186/1471-2334-12-19.CrossRefPubMedPubMedCentral
20.
go back to reference Effler PV, Bogard AK, Domen HY, Katz AR, Higa HY, Sasaki DM: Evaluation of eight rapid screening tests for acute leptospirosis in Hawaii. J Clin Microbiol. 2002, 40 (4): 1464-1469. 10.1128/JCM.40.4.1464-1469.2002.CrossRefPubMedPubMedCentral Effler PV, Bogard AK, Domen HY, Katz AR, Higa HY, Sasaki DM: Evaluation of eight rapid screening tests for acute leptospirosis in Hawaii. J Clin Microbiol. 2002, 40 (4): 1464-1469. 10.1128/JCM.40.4.1464-1469.2002.CrossRefPubMedPubMedCentral
21.
go back to reference Cohen AL, Dowell SF, Nisalak A, Mammen MP, Petkanchanapong W, Fisk TL: Rapid diagnostic tests for dengue and leptospirosis: antibody detection is insensitive at presentation. Tropical Med Int Health. 2007, 12 (1): 47-51.CrossRef Cohen AL, Dowell SF, Nisalak A, Mammen MP, Petkanchanapong W, Fisk TL: Rapid diagnostic tests for dengue and leptospirosis: antibody detection is insensitive at presentation. Tropical Med Int Health. 2007, 12 (1): 47-51.CrossRef
Metadata
Title
Human leptospirosis in The Federated States of Micronesia: a hospital-based febrile illness survey
Authors
Susannah Colt
Boris I Pavlin
Jacob L Kool
Eliaser Johnson
Judith P McCool
Alistair J Woodward
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-186

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine